Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 23, 2025Diabetes/Metabolism Research and ReviewsOpen Access

Advancements in Pharmacotherapy for Diabetic Kidney Disease: A Systematic Review

View Full Paper
Ask AI
Bookmark
Share

Authors

HZHongli ZhangJCJiewen ChenNWNiansong Wang

Discussion

Loading...

Member takes

Overview

Systematic review finds new drugs may improve renal outcomes in diabetic kidney disease, highlighting the potential of multitargeted therapies.

Key Points

  • New therapeutic drugs improve renal outcomes in patients with diabetic kidney disease, transforming treatment approaches.
  • Efficacy observed with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in clinical settings.
  • Observational analysis of existing pharmacotherapy emphasizes the importance of multitargeted strategies for managing diabetes-related kidney issues.
  • Future research must focus on standardised trials to assess long-term safety and effectiveness of traditional Chinese medicine therapies.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/68af782c7567bf4f94ff0babhttps://doi.org/10.1002/dmrr.70077
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes2016 · 6,847 citations
  2. 2Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes2024 · 1,760 citations